The WHO rules encourage the adoption of these technologies, offered they are often validated to exhibit equal or remarkable general performance when compared with regular procedures. Manufacturers aiming to employ these approaches need to offer strong validation info to demonstrate their equivalence to pharmacopoeial solutions. The ISOCAR